Loading...
Loading...
Browse all stories on DeepNewz
VisitWho will be the next major investor in Huma Therapeutics by end of 2024?
Google Ventures • 25%
Sequoia Capital • 25%
SoftBank • 25%
Other • 25%
Official announcements from Huma Therapeutics or the investor
Huma Therapeutics Raises $80M in Series D, Near-$1B Valuation
Jul 16, 2024, 11:02 AM
Huma Therapeutics, a London-based healthcare startup, has successfully raised $80 million in a Series D funding round, bringing its total funding to $300 million and valuing the company at nearly $1 billion. The funding round saw participation from notable investors including AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures, and Leaps by Bayer. Huma uses AI to help developers create health applications and aims to turn text into healthcare apps using generative AI. The startup is often referred to as the 'Shopify of digital health' and its underlying models can develop a healthcare application prototype in minutes with just a simple user prompt.
View original story
Distributed Global • 25%
Hashkey Capital • 25%
Folius Ventures • 25%
Other • 25%
Haun Ventures • 25%
Founders Fund • 25%
Sequoia Capital • 25%
Other • 25%
Venture Capital Firm • 25%
Private Equity Firm • 25%
Technology Company • 25%
Healthcare Company • 25%
A European venture capital firm • 25%
A US-based venture capital firm • 25%
A government investment fund • 25%
Sequoia Capital • 25%
Andreessen Horowitz • 25%
SoftBank • 25%
Other • 25%
Sequoia Capital • 25%
SoftBank • 25%
Tiger Global • 25%
Other • 25%
Sequoia Capital • 25%
Andreessen Horowitz • 25%
SoftBank • 25%
Other • 25%
TCGX • 25%
G. Sachs Alternatives • 25%
Avoro • 25%
Other • 25%
Claure Group • 25%
SoftBank • 25%
Sequoia Capital • 25%
Other • 25%
Yes • 50%
No • 50%
Pantera Capital • 25%
Binance Labs • 25%
Polychain • 25%
Other • 25%
Johnson & Johnson • 25%
Pfizer • 25%
GlaxoSmithKline • 25%
Other • 25%
Less than $100 million • 25%
$100 million to $200 million • 25%
$200 million to $300 million • 25%
More than $300 million • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
100% to 200% • 25%
More than 200% • 25%
Less than 50% • 25%
50% to 100% • 25%